Drug Database
Back to search

Netherlands· NL-f7442787bb60

Venoruton tabletten 500

A rutosid, kombinationen product containing hydroxyethylrutosiden, registered in Netherlands by Healthypharm B.V.. The same ATC class is registered in 3 of our 19 countries.

ATC C05CA51

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedVenoruton tabletten 500ATCC05CA51REGISTER NO.NL-f7442787bb60PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about hydroxyethylrutosidenAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Rutosid, kombinationen is registered in 3 of 19 countries.

Countries holding a registration under ATC C05CA51 (rutosid, kombinationen), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 2 of them publish a price we can compare per daily dose
Search rutosid, kombinationen products by name

Rutosid, kombinationen · ATC C05CA51

3 / 19 countries

  • Czechiaprice
  • Netherlands
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
HYDROXYETHYLRUTOSIDEN
Manufacturer
Healthypharm B.V.
Country
Netherlands (NL)
ATC code
C05CA51
ATC class
Rutosid, Kombinationen
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    16908

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under C05CA51

Rutosid, kombinationen, as other registers publish it.

All rutosid, kombinationen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/89f8c43b-2198-4b81-8640-31c9766b2dfb
GET /v1/drugs/89f8c43b-2198-4b81-8640-31c9766b2dfb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h16908_smpc.pdf",
  "strength": null,
  "atc_label": "Rutoside, Combinations",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg16908",
  "excipients": [
    "MACROGOL 6000",
    "MAGNESIUMSTEARAAT (E 470b)"
  ],
  "substances": [
    "HYDROXYETHYLRUTOSIDEN"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h16908.pdf",
  "authorised_at": "1994/08/01",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend apotheek of drogist",
  "registration_number": "16908",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about rutosid, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console